Skip to content

Psilocybin: all studies

Page 310 of 439: studies 3,091 to 3,100 of 4,389, newest first. Back to the psilocybin overview

Research

Depressions- und Angstsymptome nach psychedelisch-assistierter Psychotherapie bei therapieresistenter Depression: retrospektive Routinedatenanalyse mit vs. ohne komorbide Substanzkonsumstörung

Suchttherapie May 12, 2026 Louise Penzenstadler, Tatiana Aboulafia Brakha, Daniele Zullino

Zusammenfassung Substanzkonsumstörungen (SUD) sind chronische Erkrankungen mit hohen Rückfallraten und begrenzter Wirksamkeit etablierter Behandlungen. Vor diesem Hintergrund rückt die psychedelisch-assistierte Psychotherapie (PAP) mit Psilocybin und LSD zunehmend in den Fokus; die Literatur berichtet Hinweise auf mögliche Effekte insbesondere bei AUD und affektiven Symptomen. Ziel der Studie:...

Exploring new avenues: Psychedelic-assisted therapy for young people.

British Journal of Clinical Pharmacology May 8, 2026 Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David Nutt et al.

Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic-assisted therapy, using substances such as psilocybin and 3,4-methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including depression, anxiety and post-traumatic stress...

DOI: 10.1002/bcp.70579 (opens in new tab) Full text (opens in new tab) Adolescents Psychedelics Psychedelic‐assisted therapy Young people

From Agents to Earth Beings

Worldviews May 7, 2026 Annalisa Butticci, Osiris García Cerqueda

In Huautla de Jiménez, in the Mexican Sierra Mazateca, sacred mushrooms known as the Niños Santos (Holy Children) are openly sold in the psychedelic tourism market. Yet Mazatec healers lament that these sacred fungi are becoming increasingly difficult to find for healing ceremonies known as veladas . Faced with the extractive logics shaping global psychedelic circuits, the Niños Santos are said...

Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’

Behavioural Pharmacology May 6, 2026 Bart A. Ellenbroek, Gernot Riedel

The past two decades have seen a remarkable renaissance in research on psychedelic drugs and ketamine. Following decades of regulatory restriction that severely limited, especially clinical research, a growing body of evidence has shown that psychedelics such as lysergic acid diethylamide and psilocybin can have long-lasting beneficial effects for treatment-resistant depression, drug and...

DOI: 10.1097/fbp.0000000000000878 (opens in new tab) Ketamine Clinical pharmacology Drug Safety pharmacology +1

Song That Calls You Home

Educational Media Reviews Online May 4, 2026 Alessandra Otero

Mangoni, V. & Robledo, L. (Directors). Compuesto, Alexandra ‘Sasha’ (Producer). 2020. The Song that Calls You Home. Good Docs. 72 mins. The Song That Calls You Home is an informative documentary on plant medicine that focuses on the perceived therapeutic properties of ayahuasca. The film presents itself as an exploration of this psychedelic plant as a pathway to healing and self-discovery. Its...

DOI: 10.59236/emro.v28i4a288 (opens in new tab) Experiential learning Clarity Transparency behavior Narrative +8

The Robles Quiroz Equation: An Integration-Boundary (I-B) Model of Self-Model Collapse

Zenodo (CERN European Organization for Nuclear Research) May 3, 2026 Angel Edgardo Robles Quiroz preprint

Contemporary neuroimaging of altered states reveals a persistent paradox: pharmacologically distinct agents—specifically 5-HT2A agonists (e.g., psilocybin) and NMDA antagonists (e.g., ketamine)—produce reliably opposing network dynamics yet yield strikingly convergent phenomenological reports, notably ego dissolution and entity encounters. Current models relying on monolithic scalar metrics...

DOI: 10.5281/zenodo.20014263 (opens in new tab) Heuristic Network topology Boundary topology Falsifiability +6

Psychoplastogens: What do we know about them?

International Journal of Pharmacology and Clinical Research May 1, 2026 Jyothsna Kuralla, Harsh Chaturvedi

Major depressive disorder (MDD) remains a global health burden, with over 60% of patients failing to respond adequately to current treatments. Treatment-resistant depression (TRD), a form of MDD, highlights the urgent need for mechanistically novel antidepressants. Psychoplastogens—a class of fast-acting compounds that promote neuroplasticity—are emerging as promising alternatives to...

Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.

Cancer Reports May 1, 2026 Sepideh Hajivalizadeh, Kimia Farahmand, Kimia Kazemzadeh et al.

Depression is a prevalent comorbidity in cancer, yet conventional treatments show inconsistent efficacy. This review sought to provide a mechanism-based framework for managing cancer-related depression by exploring its unique pathophysiology and evaluating promising pharmacotherapies based on their alignment with these biological pathways. This narrative review synthesized evidence on promising...

The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences.

Journal of Psychopharmacology May 1, 2026 Vincent J Diehl, Abigail E. Calder, Gregor Hasler

Existing tools assess psychedelic experiences, but none specifically measure altered processing of traumatic memories-a key mechanism in trauma-focused therapies and psychotherapy in general. The helioscope effect describes how psychedelics like psilocybin and 3,4-methylenedioxymethamphetamine (MDMA) enable revisiting challenging or traumatic experiences while remaining protected from...